Breast Cancer
Journey
Follow Anna on her individual Cancer Pathway
1Ren W, Chen M, Qiao Y, Zhao F. Global guidelines for breast cancer screening: A systematic review. Breast. 2022 Aug;64:85-99. doi: 10.1016/j.breast.2022.04.003. Epub 2022 Apr 19. PMID: 35636342; PMCID: PMC9142711. World Cancer Research Fund International, referring to data from 2020, wcrf.org/cancer-trends/worldwide-cancer-data.
2American Cancer Society Statistics show that about 13% (about 1 in 8) of U.S. women are going to develop invasive breast cancer in the course of their life, www.breastcancer.org/facts-statistics (July 2023).
3University of Oxford https://www.ox.ac.uk/news/2023-06-13-women-diagnosed-early-breast-cancer-today-are-much-less-likely-die-disease-20-years (June 2023; American Cancer Society: https://www.cancer.org/cancer/types/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-survival-rates.html
4Compared to grid-based acquisition with Mammomat Inspiration, depending on breast thickness - L.B. Larsen, A. Fieselmann, H. Pfaff, T. Mertelmeier Performance of grid-less digital mammography acquisition technique for breast screening: analysis of 22,117 examinations Presentation B-1025 ECR 2015.
5American Cancer Society; https://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-early-detection/mammograms/breast-density-and-your-mammogram-report.html
6"The National Cancer Institute's Fact Sheet on Mammograms." National Cancer Institute. Accessed from https://www.cancer.gov/types/breast/mammograms-fact-sheet."
7Data on file. For average breast size of 50/50 glandular/adipose tissue and 5cm thickness.
8Maldera A, et al. (2016): Digital breast tomosynthesis: Dose and image quality assessment.
9Huang H, et al. (2023) Comparison of lesion detection and conspicuity between narrow-angle and wide-angle digital breast tomosynthesis for dense and non-dense breasts.
10Barr RG, Engel A, Kim S, et al. Improved Breast 2D SWE Algorithm to Eliminate False Negative Cases. Investigative Radiology. 2023
11Products mentioned herein are not commercially available in all countries. Its future availability cannot be guaranteed.
12Mann, R. M., Cho, N., & Moy, L. (2019). Breast MRI: state of the art. Radiology, 292(3), 520–536. https://doi.org/10.1148/radiol.2019182947
13MAGNETOM Flow. Platform with 70 cm bore size is currently under development. It is not for sale in the U.S.A. Its future availability cannot be guaranteed.
140.7 l of liquid helium.
15Data on file. Study ID: 2aaaa2421
16Compressed Sensing VIBE is currently under development. It is not for sale in the U.S.A. Its future availability cannot be guaranteed. Study-ID: 2aaaa3328
17Courtesy: Radboud University Medical Center, Netherlands
18Syngo Carbon consists of several products which are (medical) devices in their own right. Some products are under development and not commercially available. Future availability cannot be ensured.
19The Lancet, Volume 378, Issue 9804, 12–18 November 2011, Pages 1707-1716, https://www.sciencedirect.com/science/article/pii/S0140673611616292
20The products / features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.
21eHealth Solutions consist of several products. eHealth Virtual Visit is manufactured by Siemens Healthineers, Erlangen, Germany. Products of eHealth Solutions are not intended for diagnostic purposes. The product offerings are not commercially available in all countries.